In conclusion, we found that patients newly diagnosed with MM contain more and larger EVs in their plasma and that these EVs exert procoagulant activity, resulting in an increased thrombin generation and TF and PPL activity. The gene discussed is PPL; the disease is Miyoshi myopathy.